Natera Q4 2020 Earnings Report
Key Takeaways
Natera reported a 35.1% increase in total revenues for Q4 2020 compared to Q4 2019, driven primarily by product revenue growth. The company also saw a significant increase in the number of tests processed and reported. However, the loss from operations and net loss also increased during the same period.
Total revenues increased by 35.1% to $112.4 million compared to Q4 2019.
Product revenues grew by 43% compared to the same period last year.
Approximately 295,000 tests were processed, including 281,000 tests accessioned in Natera's laboratory.
Net loss was $76.4 million, or ($0.89) per diluted share, compared to a net loss of $35.2 million in Q4 2019.
Natera
Natera
Forward Guidance
Natera anticipates 2021 total revenue of $500 million to $525 million; 2021 cost of revenues to be approximately 47% to 52% of revenues; selling, general and administrative costs to be approximately $430 million to $450 million; research and development costs to be $160 million to $180 million, and net cash burn to be $230 million to $250 million.